Characterization of Innate Binding Specificities of Peptidoglycan Binding Protein

Information

  • Research Project
  • 8684593
  • ApplicationId
    8684593
  • Core Project Number
    R21AI111297
  • Full Project Number
    1R21AI111297-01
  • Serial Number
    111297
  • FOA Number
    PA-11-261
  • Sub Project Id
  • Project Start Date
    7/1/2014 - 10 years ago
  • Project End Date
    6/30/2016 - 8 years ago
  • Program Officer Name
    RITCHIE, ALEC
  • Budget Start Date
    7/1/2014 - 10 years ago
  • Budget End Date
    6/30/2015 - 9 years ago
  • Fiscal Year
    2014
  • Support Year
    01
  • Suffix
  • Award Notice Date
    6/30/2014 - 10 years ago
Organizations

Characterization of Innate Binding Specificities of Peptidoglycan Binding Protein

DESCRIPTION (provided by applicant): BacTx(R) technology, developed by Immunetics for detection of bacteria, employs a unique and innovative assay chemistry to detect Gram-positive and Gram-negative bacteria. The technology is based on components of the innate immune system of the tobacco hornworm (Manduca sexta), in particular the prophenoloxidase cascade, in which serine proteases cleave prophenoloxidase to phenoloxidase, which subsequently oxidizes chromogen to generate a colored reaction product. The BacTx(R) Bacterial Detection Kit received 510(k) clearance from the FDA (CBER) in June 2012 as a quality control test for bacterial contamination in platelets. For M. sexta and other Lepidoptera, the most potent elicitor of the prophenoloxidase cascade is peptidoglycan, which is a major structural component of bacterial cell walls. In this application we propose to biochemically characterize the relationship between the presence of specific bacterial cell wall features and evasion of detection by pathogen recognition proteins present in M. sexta hemolymph. The role of these features in inhibiting prophenoloxidase activation will be investigated, with the long term goal of potentially enhancing assay performance and opening up new applications of BacTx(R) technology, including potential use for diagnosis of sepsis, meningitis, and nosocomial infections. Due to the striking similarities between the insect innate immune system and human complement system, this research may also prove significant to elucidating the relationship between inflammation due to bacterial infection and debilitating disorders such as cancer, autoimmune diseases, and septic shock.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R21
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
    150000
  • Indirect Cost Amount
    93150
  • Total Cost
    243150
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:243150\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    IMMUNETICS, INC.
  • Organization Department
  • Organization DUNS
    174347732
  • Organization City
    BOSTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    022102377
  • Organization District
    UNITED STATES